astragaloside a has been researched along with Chronic Kidney Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, D; Ji, C; Li, Y; Liu, X; Lu, Z; Mo, Y; Yu, W | 1 |
| Cao, W; He, Q; Li, D; Liu, Y; Peng, Z; Tan, Q; Wang, J; Wang, S; Zeng, Y; Zhan, Q | 1 |
| Fu, Z; Jia, Q; Sun, Z; Wang, X; Xia, J; Xue, L; Zhang, L; Zhou, L | 1 |
| Bao, X; Dong, P; Sun, Z; Wang, X; Xia, J; Xu, Z; Xue, L; Zhou, L | 1 |
| Bai, L; Chen, D; Chen, J; Li, H; Li, J; Lin, H; Liu, B; Lu, R; Pang, Y; Wu, J; Zhang, P; Zhou, J; Zhou, Y | 1 |
5 other study(ies) available for astragaloside a and Chronic Kidney Diseases
| Article | Year |
|---|---|
Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway.
Topics: Animals; Epithelial Cells; Indican; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic | 2023 |
Astragaloside IV Blunts Epithelial-Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy.
Topics: Aldehyde Dehydrogenase, Mitochondrial; Animals; Apoptosis; Autophagy; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Fibrosis; G2 Phase Cell Cycle Checkpoints; Humans; Molecular Docking Simulation; Proto-Oncogene Proteins c-akt; Rats; Renal Insufficiency, Chronic; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1; Tumor Suppressor Protein p53 | 2023 |
Pharmacokinetic-pharmacodynamic modeling of the active components of Shenkang injection in rats with chronic renal failure and its protective effect on damaged renal cells.
Topics: Animals; Drugs, Chinese Herbal; Emodin; Fibrosis; Kidney; Kidney Failure, Chronic; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2023 |
Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology-Molecular docking-Key target validation".
Topics: Animals; Drugs, Chinese Herbal; Emodin; Kidney Failure, Chronic; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Renal Insufficiency, Chronic | 2023 |
Protective role of Astragaloside IV in chronic glomerulonephritis by activating autophagy through PI3K/AKT/AS160 pathway.
Topics: Animals; Astragalus propinquus; Autophagy; Cells, Cultured; Cytoprotection; Glomerulonephritis; GTPase-Activating Proteins; Humans; Kidney; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Saponins; Signal Transduction; Triterpenes | 2020 |